Flunixin meglumine

Flunixin meglumine is an organoammonium salt obtained by combining flunixin with one molar equivalent of 1-deoxy-1-(methylamino)-D-glucitol. A relatively potent non-narcotic, nonsteroidal analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties; used in veterinary medicine for treatment of horses, cattle and pigs. Among its listed roles, it functions as a antipyretic, a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor. It includes a flunixin(1-). It is grouped under the following drug class(es): Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Banamine, finadyne, VetaMeg and Flunazine. Its PubChem CID is 39212.

CAS No 42461-84-7
Molecular Formula C21H28F3N3O7
Molecular Weight 491.5 g/mol
Synonyms (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid

Frequently Asked Questions